Company intelligence / Profile preview
Moderna Inc
Cambridge, Massachusetts, United Statesproducts.modernatx.com ↗
- Ownership
- Public · MRNA
- Employees
- ~5800
- Development stage
- Commercial
01
Overview
Moderna has successfully developed and commercialized its COVID-19 vaccine (SPIKEVAX) which received full FDA approval. The company has also received approval for its RSV vaccine (mRESVIA) in the U.S., Europe, Canada, and Qatar.
- Therapeutic areas
- PulmonologyCardiovascularMetabolic DisordersOncologyRare DiseasesInfectious Diseases
- Modalities
- mRNA therapeuticsmRNA vaccines
- Industry
- Pharma
02
Drug pipeline
150 assets149 more assets in the full pipeline.
Request access →03
Partnerships
04
Financials
- Market cap
- $53.8B
- Total revenue
- $145M
- Enterprise value
- $50B
Beyond the preview
Go deeper on Moderna Inc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Moderna Inc.